Fibrin β15-42 domain is cryptic in intact fibrinogen: Comment on the study by A. Sahni et al.

International Journal of Cancer

Volumn 127, Issue 12, 2010, Pages 2981-2982

  Weijers, Ester M ^a   Koolwijk, Pieter ^a   Van Hinsbergh, Victor W M ^a   Van Nieuw Amerongen, Geerten P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRIN BETA[15-42]; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; MONOMER; PEPTIDE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

CELL JUNCTION; CELL MIGRATION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; TUMOR CELL;

ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; PEPTIDE FRAGMENTS;

EID: 78249271737     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25280     Document Type: Letter

References (9)

1. Sahni A, Arevalo MT, Sahni SK, Simpson-Haidaris PJ,. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Int J Cancer 2009; 125: 577 -84.
2. Tyagi N, Roberts AM, Dean WL, Tyagi SC, Lominadze D,. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 2008; 307: 13 -22.
3. Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME,. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol 1984; 21: 89 -94.
4. Mosesson MW,. Fibrinogen and fibrin structure and functions. J Thromb Hemost 2005; 3: 1894 -1904.
5. Guadiz G, Sporn LA, Simpson-Haidaris PJ,. Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices. Blood 1997; 90: 2644 -53.
6. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VWM,. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 2007; 27: 2332 -39.
7. Ge M, Ryan TJ, Lum H, Malik AB,. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol 1991; 261: L283 -L289.
8. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH,. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96: 3302 -09.
9. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL,. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002; 62: 6966 -72.